1. Home
  2. CREX vs LGVN Comparison

CREX vs LGVN Comparison

Compare CREX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.70

Market Cap

40.6M

Sector

Technology

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.77

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREX
LGVN
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
34.0M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
CREX
LGVN
Price
$3.70
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
33.7K
463.2K
Earning Date
04-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
50.76
EPS
N/A
N/A
Revenue
$18,437,000.00
$709,000.00
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
$10.81
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$1.97
$0.48
52 Week High
$4.42
$1.80

Technical Indicators

Market Signals
Indicator
CREX
LGVN
Relative Strength Index (RSI) 45.08 30.82
Support Level $3.52 $0.74
Resistance Level $3.77 $0.84
Average True Range (ATR) 0.17 0.06
MACD -0.03 -0.02
Stochastic Oscillator 4.98 0.04

Price Performance

Historical Comparison
CREX
LGVN

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: